Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2012 | Volume: 8 | Issue: 5 | Page No.: 459-462
DOI: 10.3923/ijp.2012.459.462
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Efficacies of Regulatory Policies to Control Massive Use of Diphenoxylate
Amir Farshchi, Mona Jaberidoost, Akbar Abdollahiasl and Mohammad Abdollahi

Abstract:
Iran has been one of the highest users of diphenoxylate in the world in 2008. Iranian food and drug organisation (FDO) established some rules to control the usage of this drug included rationalizing the supply and doubling the price. Data were gathered from the distributors and wholesalers of this medicine in the country during 2006-2010. These data were cross-checked with importation data in the Ministry of Health and a trend analysis was tabulated. In 2009, the average consumption reached to less than 650 million tablets which show 42% decrease in comparison to the previous year. After the second intervention, there has been no significant change in the trend. The first intervention has controlled the use of diphenoxylate by reduction of market need and lessening diphenoxylate unauthorized use. Data do not support the efficiency of second intervention meaning that doubling the price does not work.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Cost and Utilization Study of Antidotes: An Iranian Experience
How to cite this article:

Amir Farshchi, Mona Jaberidoost, Akbar Abdollahiasl and Mohammad Abdollahi, 2012. Efficacies of Regulatory Policies to Control Massive Use of Diphenoxylate. International Journal of Pharmacology, 8: 459-462.

DOI: 10.3923/ijp.2012.459.462

URL: https://scialert.net/abstract/?doi=ijp.2012.459.462

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom